Jabil Upgraded by UBS on AI Growth Potential for Alphabet

What happened

UBS upgraded circuit board manufacturer Jabil from neutral to buy with a $430 price target, representing approximately 28% upside from recent levels. The upgrade reflects expectations for sustained growth driven by hyperscaler AI spending, healthcare demand, and automation markets. UBS raised its fiscal 2027 and 2028 earnings-per-share estimates to $16.78 and $20.24 respectively, citing stronger demand signals from cloud and data center infrastructure customers. The firm expects Jabil's operating margin to exceed 6% in fiscal 2027, up from the current 5.8%. Jabil shares gained about 5% following the upgrade announcement.

Why it matters

As a key supplier to major hyperscalers including Alphabet, Amazon, and Meta, Jabil's growth trajectory provides insight into the scale of AI infrastructure investment. The four major hyperscalers are projected to spend nearly $700 billion on AI initiatives in 2026, with total U.S. hyperscaler AI capital expenditures potentially exceeding $1 trillion by year-end according to Goldman Sachs Research. UBS expects Jabil's AI-related revenue to grow at least 50% in fiscal 2027 to approximately $20.3 billion, indicating robust demand for the circuit boards and components that power AI data centers. The firm's recent capacity expansions in Memphis and North Carolina, along with product roadmaps at customers like Amazon Web Services' chip business, suggest accelerating infrastructure buildouts that will support Alphabet's AI ambitions.

Bigger picture

Jabil's business transformation reflects broader industry trends in AI infrastructure supply chains. The company has deliberately shifted away from lower-margin businesses toward high-growth markets including robotics, automation, and healthcare. UBS highlighted that Jabil's Digital Commerce business, representing about $2.7 billion or 8% of fiscal 2026 revenue, operates at margins above 7%, exceeding the company's overall 5.8% margin. The firm's Croatia facility has been repurposed for healthcare customers to capitalize on demand for higher-margin products including GLP-1 drugs. This strategic repositioning toward AI and healthcare mirrors similar moves across the electronics manufacturing services sector as suppliers align with secular growth trends. UBS applied a roughly 22-times price-to-earnings multiple to its earnings estimates, down from 25 times, reflecting what it described as broad-based derating across AI infrastructure stocks despite maintaining strong growth expectations.

What to watch

Monitor Jabil's quarterly results for evidence of the beat-and-raise pattern UBS expects to support its valuation thesis. Key indicators include AI-related revenue growth rates, operating margin progression toward the 6% target, and commentary on capacity utilization at expanded facilities. Watch for updates on product roadmaps and order patterns from major hyperscaler customers, particularly Amazon Web Services' chip business and Meta's infrastructure plans. Healthcare segment performance as the Croatia facility ramps production will signal whether margin expansion materializes as forecast. Any changes in hyperscaler capital expenditure guidance could materially impact Jabil's growth trajectory given its dependence on AI infrastructure spending.